Cornea News and Research

RSS

Free resource provides correct information about corneal dystrophies

Jayne Weiss, MD, Associate Dean of Clinical Affairs, Professor and Chair of Ophthalmology at LSU Health New Orleans School of Medicine, is the lead author of an editorial about inaccuracies in the medical literature that medical professionals rely upon to diagnose corneal dystrophies, as well as a free resource that provides correct information.

7 Nov 2018

A fully human cell culture system for growing skin keratinocytes

Breakthrough research to culture human skin cells called keratinocytes to produce skin grafts has been published by a team of researchers from Duke-NUS Medical School and the Singapore General Hospital.

31 Oct 2018

Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera).

31 Oct 2018

$The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award$

The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery.

22 Oct 2018

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers at the University of Illinois at Chicago have received a four-year, $5.25 million grant from the U.S. Department of Defense to lead a multi-site clinical trial to test the efficacy of a stem cell-based treatment for eye injuries.

5 Oct 2018

Novel discovery could help to improve success of corneal transplants

A team of eye specialists at The University of Nottingham has made another novel discovery that could help to improve the success of corneal transplants for patients whose sight has been affected by disease.

1 Oct 2018

New outbreak of rare eye disease identified in contact lens wearers

A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.

21 Sep 2018

FDA approves first drug for treatment of rare disease affecting the cornea

The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

23 Aug 2018

Common signs that indicate vision problems in children

Healthy vision is essential to a child's success in the classroom. Some children may eventually require glasses.

14 Aug 2018

Blue light from smart phones and digital devices could raise risk of blindness

According to researchers, the blue light from laptops, smart phones and other digital devices, could raise the risk of blindness. The study appears in the latest issue of the journal Scientific Reports.

10 Aug 2018

Injecting vasoactive intestinal peptide into the eye enhances corneal graft survival

A new study in the American Journal of Pathology reports for the first time that injection of neuropeptide vasoactive intestinal peptide directly into the eye of mice enhanced corneal graft survival.

7 Aug 2018

New research project investigates alternative treatments for eye infections

Fight for Sight has announced funding for an innovative research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection.

20 Jul 2018

Research project investigates snake venom treatment as antibiotic alternative for eye infections

An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.

19 Jul 2018

Researchers identify 161 genetic factors for myopia

The international Consortium for Refractive Error and Myopia recently published the worldwide largest genetic study of myopia in Nature Genetics. Researchers from the Gutenberg Health Study at the Medical Center of Johannes Gutenberg University Mainz participated in this study, which identified 161 genetic factors for myopia.

14 Jun 2018

UK scientists 3D-print the first human corneas

For the first time in history, scientists from have 3D-printed human corneas, providing a potential solution to the current shortage of corneas for transplant.

1 Jun 2018

FDA approves first stand-alone prosthetic iris in the U.S.

The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.

30 May 2018

Columbia researchers develop new non-invasive approach to permanently correct vision

Nearsightedness, or myopia, is an increasing problem around the world. There are now twice as many people in the US and Europe with this condition as there were 50 years ago. In East Asia, 70 to 90 percent of teenagers and young adults are nearsighted.

29 May 2018

New non-invasive approach could permanently correct vision

Nearsightedness, or myopia, is an increasing problem around the world. There are now twice as many people in the US and Europe with this condition as there were 50 years ago.

29 May 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

FDA grants clearance for first contact lens with light-adaptive technology

The U.S. Food and Drug Administration today cleared the first contact lens to incorporate an additive that automatically darkens the lens when exposed to bright light.

11 Apr 2018